Work

Abstract PS2-10-01: Mutational profiles from liquid biopsies in early versus late progressors treated with CDK inhibitors in 1st line metastatic breast cancer

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps2-10-01

Authors: M. Brichard, C. Roussel-Simonin, M. Ibanez Alda, J. Araujo, J. Doxon-Douglas, C. Bousrih, C. Poisson, A. Sabau, T. Grinda, A. Viansone, L. Antoun, S. AKLA, E. Rassy, J. Zeghondy, F. Giugliano, B. Verret, C. Nicotra, M. NgoCamus, A. Bayle, B. Pistilli, A. Italiano, J. M. Ribeiro, A. Fernandez-Martinez

Institutions: Cliniques Universitaires Saint-Luc, Institut Gustave Roussy, Marqués de Valdecilla University Hospital, Unidade Local de Saúde Santa Maria, Institut Bergonié

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130727198

Cites:

Cited by:

Related to: